OPEN

Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. | Psychotherapy and psychosomatics | December 2020

By OPEN|2021-03-24T17:44:23+01:001 December 2020|Tags: C. Barbui, C. Gastaldon, E. Raschi, G. Schoretsanitis, J. Kane|

Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom

Nkadimeng, S. M., Nabatanzi, A., Steinmann, C. M., & Eloff, J. N. | Plants | 31 August 2020

By OPEN|2021-03-24T17:38:00+01:0031 August 2020|Tags: A. Nabatanzi, C. Steinmann, J. Eloff, S. Nkadimeng|

Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin

Madsen, M. K., & Knudsen, G. M. | Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology | 25 August 2020

By OPEN|2021-03-24T17:09:14+01:0025 August 2020|Tags: G. Knudsen, M. Madsen|

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

Ramaekers, J. G., Hutten, N., Mason, N. L., Dolder, P., Theunissen, E. L., Holze, F., ... & Kuypers, K. P. | Journal of Psychopharmacology | 25 August 2020

By OPEN|2021-03-24T17:14:39+01:0025 August 2020|Tags: E. Theunissen, F. Holze, J. Ramaekers, K. Kuypers, N. Hutten, N. Manson, P. Dolder|

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies

Breeksema, J. J., Niemeijer, A. R., Krediet, E., Vermetten, E., & Schoevers, R. A | CNS drugs | 17 August 2020

By OPEN|2021-03-24T17:22:09+01:0017 August 2020|Tags: A. Niemeijer, E. Krediet, E. Vermetten, J. Breeksema, R. Schoevers|

The rise, fall, and possible rise of LSD

Snelders, S., & Pieters, T. |  Tijdschrift Voor Psychiatrie | August 2020

By OPEN|2021-03-08T18:47:29+01:001 August 2020|Tags: S. Snelders, T. Pieters|

The Current Status of Psychedelics in Psychiatry

Nutt, D., & Carhart-Harris, R. | JAMA psychiatry | 29 July 2020

By OPEN|2021-03-08T18:53:34+01:0029 July 2020|Tags: D. Nutt, R. Carhart-Harris|

Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms

Morita, I., Oyama, H., Kiguchi, Y., Oguri, A., Fujimoto, N., Takeuchi, A., ... & Kobayashi, N. | Journal of Pharmaceutical and Biomedical Analysis | 21 July 2020

By OPEN|2021-03-24T17:35:49+01:0021 July 2020|

Ibogaine therapy for addiction: Consumer views from online fora

Barber, M., Gardner, J., Savic, M., & Carter, A. | Journal of Drug Policy | 18 July 2020

By OPEN|2021-03-08T18:32:33+01:0018 July 2020|Tags: A. Carter, J. Gardner, M. Barber, M. Savic|

Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use

Roberts, C. A., Osborne-Miller, I., Cole, J., Gage, S. H., & Christiansen, P. | Journal of Psychopharmacology| 17 July 2020

By OPEN|2021-03-08T18:23:26+01:0017 July 2020|Tags: C. Roberts, I. Osborne-Miller, J. Cole, P. Christiansen, S. Gage|